Avalo Therapeutics (AVTX) Enterprise Value (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.74% |
| Dec 31, 2025 | 2.63% |
| Sep 30, 2025 | -19.37% |
| Jun 30, 2025 | 43.23% |
| Mar 31, 2025 | 7.06% |
| Dec 31, 2024 | -64.37% |
| Sep 30, 2024 | 12.38% |
| Jun 30, 2024 | 15.20% |
| Mar 31, 2024 | -11,017,600.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 93.33% |
| Jun 30, 2023 | 99.91% |
| Mar 31, 2023 | -111,146.67% |
| Dec 31, 2022 | 99.91% |
| Sep 30, 2022 | -120,921.43% |
| Jun 30, 2022 | 86.00% |
| Mar 31, 2022 | 99.82% |
| Dec 31, 2021 | 23.66% |
| Sep 30, 2021 | -76.84% |
| Jun 30, 2021 | -5.60% |
| Mar 31, 2021 | -100,668.42% |
| Dec 31, 2020 | 71.21% |
| Sep 30, 2020 | -300.00% |
| Jun 30, 2020 | 99.78% |
| Mar 31, 2020 | -93.21% |
| Dec 31, 2019 | -7,380.86% |
| Sep 30, 2019 | 98.91% |
| Jun 30, 2019 | 41.77% |
| Mar 31, 2019 | -85,972.55% |
| Dec 31, 2018 | 49.42% |
| Sep 30, 2018 | 98.30% |
| Jun 30, 2018 | 13.64% |
| Mar 31, 2018 | 3.13% |
| Dec 31, 2017 | 89.12% |
| Sep 30, 2017 | -180,015.77% |
| Jun 30, 2017 | 99.56% |
| Mar 31, 2017 | 42.30% |
| Dec 31, 2016 | 40.99% |
| Sep 30, 2016 | 25.80% |
| Jun 30, 2016 | 28.44% |
| Mar 31, 2016 | 21.55% |
| Dec 31, 2015 | -539.72% |
| Sep 30, 2015 | 46.15% |
| Jun 30, 2015 | 29.04% |
| Mar 31, 2015 | 26.27% |
| Dec 31, 2014 | 25.36% |